BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27879573)

  • 1. Multimodal Analgesia Versus Intravenous Patient-Controlled Analgesia for Minimally Invasive Transforaminal Lumbar Interbody Fusion Procedures.
    Singh K; Bohl DD; Ahn J; Massel DH; Mayo BC; Narain AS; Hijji FY; Louie PK; Long WW; Modi KD; Kim TD; Kudaravalli KT; Phillips FM; Buvanendran A
    Spine (Phila Pa 1976); 2017 Aug; 42(15):1145-1150. PubMed ID: 27879573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal Versus Patient-Controlled Analgesia After an Anterior Cervical Decompression and Fusion.
    Bohl DD; Louie PK; Shah N; Mayo BC; Ahn J; Kim TD; Massel DH; Modi KD; Long WW; Buvanendran A; Singh K
    Spine (Phila Pa 1976); 2016 Jun; 41(12):994-998. PubMed ID: 26679869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial.
    Haws BE; Khechen B; Patel DV; Bawa MS; Ahn J; Bohl DD; Mayo BC; Massel DH; Guntin JA; Cardinal KL; Singh K
    J Neurosurg Spine; 2018 Nov; 30(2):222-227. PubMed ID: 30497132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postoperative pain management after minimally invasive hysterectomy: thoracic epidural analgesia versus intravenous patient-controlled analgesia].
    Hensel M; Frenzel J; Späker M; Keil E; Reinhold N
    Anaesthesist; 2013 Oct; 62(10):797-807. PubMed ID: 24057760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Narcotic Consumption in Workman's Compensation Patients Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Ahn J; Bohl DD; Elboghdady I; Aboushaala K; Mayo BC; Hassanzadeh H; Singh K
    Spine (Phila Pa 1976); 2015 Aug; 40(16):1284-8. PubMed ID: 25996538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a Standardized Multimodal Postoperative Analgesia Protocol Improves Pain Control, Reduces Opioid Consumption, and Shortens Length of Hospital Stay After Posterior Lumbar Spinal Fusion.
    Walker CT; Gullotti DM; Prendergast V; Radosevich J; Grimm D; Cole TS; Godzik J; Patel AA; Whiting AC; Little A; Uribe JS; Kakarla UK; Turner JD
    Neurosurgery; 2020 Jul; 87(1):130-136. PubMed ID: 31414128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Preoperative Medications on Length of Stay, Inpatient Pain, and Narcotics Consumption After Minimally Invasive Transforaminal Lumbar Interbody Fusion.
    Haws BE; Khechen B; Patel DV; Bawa MS; Guntin JA; Cardinal KL; Wiggins AB; Singh K
    Clin Spine Surg; 2019 Feb; 32(1):E37-E42. PubMed ID: 30234567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs.
    Haws BE; Khechen B; Narain AS; Hijji FY; Cardinal KL; Guntin JA; Singh K
    Spine (Phila Pa 1976); 2018 Sep; 43(18):1307-1312. PubMed ID: 29462060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Transforaminal Versus Direct Lateral Lumbar Interbody Fusion: Effect on Return to Work, Narcotic Use, and Quality of life.
    Verla T; Winnegan L; Mayer R; Cherian J; Yaghi N; Palejwala A; Omeis I
    World Neurosurg; 2018 Aug; 116():e321-e328. PubMed ID: 29738856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative multimodal analgesia decreases 24-hour postoperative narcotic consumption in elective spinal fusion patients.
    Haffner M; Saiz AM; Nathe R; Hwang J; Migdal C; Klineberg E; Roberto R
    Spine J; 2019 Nov; 19(11):1753-1763. PubMed ID: 31325627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ketorolac on posterior minimally invasive transforaminal lumbar interbody fusion: an interim analysis from a randomized, double-blinded, placebo-controlled trial.
    Claus CF; Lytle E; Lawless M; Tong D; Sigler D; Garmo L; Slavnic D; Jasinski J; McCabe RW; Kaufmann A; Anton G; Yoon E; Alsalahi A; Kado K; Bono P; Carr DA; Kelkar P; Houseman C; Richards B; Soo TM
    Spine J; 2022 Jan; 22(1):8-18. PubMed ID: 34506986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion: 2-year assessment of narcotic use, return to work, disability, and quality of life.
    Adogwa O; Parker SL; Bydon A; Cheng J; McGirt MJ
    J Spinal Disord Tech; 2011 Dec; 24(8):479-84. PubMed ID: 21336176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Recovery After Surgery Pathway for Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion Decreases Length of Stay and Opioid Consumption.
    Kerolus MG; Yerneni K; Witiw CD; Shelton A; Canar WJ; Daily D; Fontes RBV; Deutsch H; Fessler RG; Buvanendran A; O'Toole JE
    Neurosurgery; 2021 Feb; 88(3):648-657. PubMed ID: 33469652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microendoscopy-Assisted Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion for Lumbar Degenerative Diseases: 5-Year Outcomes.
    Yang Y; Liu ZY; Zhang LM; Pang M; Chhantyal K; Wu WB; Chen ZH; Luo CX; Rong LM; Liu B
    World Neurosurg; 2018 Aug; 116():e602-e610. PubMed ID: 29778600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcomes of minimally invasive versus open transforaminal lumbar interbody fusion: a matched-pair comparison study.
    Seng C; Siddiqui MA; Wong KP; Zhang K; Yeo W; Tan SB; Yue WM
    Spine (Phila Pa 1976); 2013 Nov; 38(23):2049-55. PubMed ID: 23963015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative narcotic utilization: accuracy of patient self-reporting and its association with postoperative narcotic consumption.
    Ahn J; Bohl DD; Tabaraee E; Aboushaala K; Elboghdady IM; Singh K
    J Neurosurg Spine; 2016 Jan; 24(1):206-14. PubMed ID: 26360141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinal versus general anesthesia for minimally invasive transforaminal lumbar interbody fusion: implications on operating room time, pain, and ambulation.
    De Biase G; Gruenbaum SE; West JL; Chen S; Bojaxhi E; Kryzanski J; Quiñones-Hinojosa A; Abode-Iyamah K
    Neurosurg Focus; 2021 Dec; 51(6):E3. PubMed ID: 34852316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wound infiltration with ropivacaine as an adjuvant to patient controlled analgesia for transforaminal lumbar interbody fusion: a retrospective study.
    Li K; Ji C; Luo D; Feng H; Yang K; Xu H
    BMC Anesthesiol; 2020 Nov; 20(1):288. PubMed ID: 33208089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of radiographic and clinical outcomes of an articulating expandable interbody cage in minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis.
    Massie LW; Zakaria HM; Schultz LR; Basheer A; Buraimoh MA; Chang V
    Neurosurg Focus; 2018 Jan; 44(1):E8. PubMed ID: 29290133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Gender Influence Postoperative Outcomes in Minimally Invasive Transforaminal Lumbar Interbody Fusion?
    Khechen B; Haws BE; Patel DV; Cardinal KL; Guntin JA; Singh K
    Clin Spine Surg; 2019 Mar; 32(2):E107-E111. PubMed ID: 30407263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.